BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Alcohol
,
Prozac
,
rs6983267
,
ZBTB7A
,
nitric oxide metabolic process
,
Allergy to pollen
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
heart neoplasms
Summary
General Info
Curated Studies
Most Correlated Studies
OMIM - Neoplasms
OMIM - Congenital disorder
Breast, endometrial and ovarian cancer cell lines treated with eribulin or paclitaxel
OMIM - Vascular disease
Cardiomyocytes (HL-1) overexpressing NCAM1 isoform CD56-140KD
Explore Curated Studies Results
Literature
Most Relevant Literature
A dangling right heart tumour.
Radiomics Feature Analysis Using Native T1 Mapping for Discriminating Between Cardiac Tumors and Thr…
Case 315: Cardiac Calcified Amorphous Tumor.
Primary cardiac low-grade neuroendocrine tumor: a case report and review of the literature.
Differential and prognostic value of cardiovascular magnetic resonance derived scoring algorithm in …
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
A Study of LY2784544 in Participants With Myeloproliferative Neoplasms
Study of Molecular and Genetic Abnormalities in Patients With Myeloid Neoplasms
Cabozantinib in High Grade Neuroendocrine Neoplasms
Clinical Investigation Of The Mitroflow Aortic Pericardial Heart Valve
Study of LY2784544 Testing Alternative Dosing in Participants With Myeloproliferative Neoplasms
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ